Patient-voice sources — colorectal adenocarcinoma¶
All PubMed identifiers below were re-verified through live PubMed E-utilities queries in the audit session. Organization URLs were fetched live on 2026-08-30. This is an annotated, purposive set rather than a systematic-review bibliography.
A. Qualitative syntheses and broad experience studies¶
| Source | Contribution to this layer | Important limit |
|---|---|---|
| Rutherford et al., qualitative meta-synthesis (2020), PMID 32335745 | Broad map of living with and beyond colorectal cancer; supports the pathway and adaptation framing. | Included studies vary by treatment era, country and disease site. |
| Harrington et al. (2010), PMID 20848873 | Long-term symptoms and consequences after colorectal-cancer treatment. | Older treatment era; survivorship samples exclude people who died early. |
| Wiltink et al. (2020), PMID 32025805 | Evidence-based guidance on long-term physical and psychosocial impairments. | Guideline synthesis is not itself a qualitative study. |
| Fernandes et al. (2024), PMID 39361213 | Late non-gastrointestinal symptom burden in survivors. | Survivor population may underrepresent advanced disease and poor access. |
B. Bowel function, stomas and organ preservation¶
| Source | Contribution | Important limit |
|---|---|---|
| Pieniowski et al. (2020), PMID 32530135 | Long-term prevalence and quality-of-life association of low anterior resection syndrome. | Instrument-defined syndrome does not capture every contextual burden. |
| Pachler and Wille-Jørgensen (2012), PMID 23235607 | Quality-of-life evidence after permanent colostomy. | Heterogeneous studies and instruments; not a simple causal comparison. |
| Pape et al. (2021), PMID 34543812 | Patient information and support needs around stoma reversal. | Specific health-system and procedural context. |
| Yeniğűn Akbulut et al. (2026), PMID 41578363 | Qualitative meta-synthesis of psychosocial experiences with a stoma. | Recent synthesis; included studies may differ in diagnosis and stoma type. |
| Custers et al. (2023), PMID 36988922 | Quality of life and function during watch-and-wait. | Selected complete responders in specialist surveillance. |
| Verheij et al. (2024), PMID 37883738 | Long-term organ-preservation outcomes from OPRA. | Trial centers and response-selected population constrain generalization. |
C. Sexual function and treatment effects¶
| Source | Contribution | Important limit |
|---|---|---|
| Wallington et al. (2021), PMID 32777386 | Sexual dysfunction and counseling gaps after colorectal-cancer treatment. | Measurement and populations vary; LGBTQ+ experiences may be underrepresented. |
| Arthur et al. (2018), PMID 29947348 | Review of interventions addressing sexual wellbeing. | Small, heterogeneous intervention evidence. |
| Kuriyama et al. (2018), PMID 29280005 | Prevention evidence for chemotherapy-induced neuropathy. | Prevention efficacy is not equivalent to lived-experience evidence. |
D. Screening experience and barriers¶
| Source | Contribution | Important limit |
|---|---|---|
| Honein-AbouHaidar et al. (2016), PMID 27197277 | Qualitative synthesis of screening barriers and facilitators. | Program and population differences limit a universal hierarchy of barriers. |
| Lim et al. (2021), PMID 32694277 | Colonoscopy-specific barriers and facilitators. | Findings depend on screening invitation and health-system design. |
| Chin et al. (2020), PMID 32740167 | Patient perspectives on stool-based screening. | Test technology and messaging can date quickly. |
| Travis et al. (2020), PMID 32539187 | Perspectives in groups with low screening uptake. | Targeted samples are analytically valuable but not population prevalence estimates. |
| Le Bonniec et al. (2022), PMID 35705780 | Umbrella-level synthesis of screening barriers. | Inherits heterogeneity and limitations of component reviews. |
E. Financial, geographic and structural inequity¶
| Source | Contribution | Important limit |
|---|---|---|
| Azzani et al. (2024), PMID 38182993 | Systematic review of financial toxicity in colorectal cancer. | Cost definitions and health systems differ substantially. |
| Bhimani et al. (2022), PMID 36063775 | Economic burden associated with metastatic colorectal-cancer treatment. | Claims and cost studies incompletely measure household distress. |
| Islami et al. (2024), PMID 37962495 | Population disparities in colorectal-cancer burden and outcomes. | Describes associations, not a single causal pathway. |
| Tobin et al. (2023), PMID 36890731 | Rurality, race and survival. | Geography and race proxy multiple mechanisms not resolved by registry data. |
| Iezzoni et al. (2022), PMID 35358465 | Barriers to cancer care among people with disabilities. | Not limited to colorectal cancer; applied here as an access-design source. |
F. Young-onset and inherited disease¶
| Source | Contribution | Important limit |
|---|---|---|
| Spaander et al. (2023), PMID 37105987 | Epidemiology and unresolved causes of young-onset colorectal cancer. | Broad review, not primary qualitative patient testimony. |
| Uson et al. (2022), PMID 33857637 | Cascade testing after hereditary-cancer findings. | Testing pathways vary by health system and family structure. |
| Mol et al. (2025), PMID 40356044 | Mental-health burden in familial adenomatous polyposis. | Rare-syndrome samples are small and referral-selected. |
G. Verified organization pages¶
| Publisher | Page fetched | Use in this layer |
|---|---|---|
| Colorectal Cancer Alliance | https://colorectalcancer.org/ and https://colorectalcancer.org/resources-support/ | Navigation, financial, family, young-onset, palliative and hospice support. |
| Fight Colorectal Cancer | https://fightcolorectalcancer.org/ | Education, biomarkers, trials, community and policy advocacy. |
| Bowel Cancer UK | https://www.bowelcanceruk.org.uk/how-we-can-help/ | Nurse and peer support, publications, carer and bereavement resources. |
| Bowel Cancer Australia | https://www.bowelcanceraustralia.org/support-care/support-for-you/ | Nursing, nutrition, psychosocial, exercise, buddy and group support. |
| Digestive Cancers Europe | https://digestivecancers.eu/for-patients/ | Local organization finder, trial information, patient/carer network and multilingual information. |
| Global Colon Cancer Association | https://www.globalcca.org/ | Multinational network, education, biomarkers and equity advocacy. |
| Colorectal Cancer Canada | https://www.colorectalcancercanada.com/what-we-do/support/ | Support specialists, groups, resources and digital peer community. |
| Bowel Cancer New Zealand | https://bowelcancernz.org.nz/contact/ and https://bowelcancernz.org.nz/resources/ | Nurse contact, resources and translated material. |
| CORUM | https://corum.com.my/about/ and https://corum.com.my/all_helpie_faq_page/ | Survivor-led peer and psychosocial support, practical stoma/diet information and education. |
| Cancer Association of South Africa | https://cansa.org.za/contact-us/ | Cancer-wide help desk, regional care centers, multilingual messaging and tele-counseling. |
H. Sources deliberately not used¶
- Private Facebook, WhatsApp and forum content was not accessed.
- Search-result snippets were not treated as verification.
- Individual organization testimonials were not mined or cross-linked.
- Commercial treatment-center marketing pages were not used as patient-experience evidence.
- Social-media posts were not sampled because consent, representativeness and context could not be assured within this build.
Coverage limits¶
- Geography: the peer-reviewed and organizational record is weighted toward North America, Western Europe and Australasia. Africa, Latin America, the Middle East and much of Asia are not adequately represented.
- Language: this build primarily searched and synthesized English-language material. Translated organization resources do not repair this research imbalance.
- Selection: qualitative studies recruit people who reached care and agreed to participate. Those with the poorest access, greatest illness burden or distrust of institutions may be missing.
- Survivorship bias: long-term outcome studies necessarily omit many people with rapidly fatal or untreated disease.
- Treatment era: stoma, radiotherapy, systemic-treatment and surveillance experiences change as techniques evolve.
- Identity: sexual/gender minorities, people with disabilities, Indigenous populations, migrants and people without stable housing are rarely analyzed with enough depth for separate colorectal-specific themes.
- Caregivers: family and bereavement services are visible, but the focused literature retrieval did not support a full independent caregiver synthesis.
- Digital divide: online communities and web resources may improve access for some while excluding people without connectivity, devices, literacy or privacy.
These gaps should be treated as research and service-design questions, not as evidence that the corresponding burdens are absent.